Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
出版年份 2023 全文链接
标题
Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
作者
关键词
-
出版物
Frontiers in Neurology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-03-22
DOI
10.3389/fneur.2023.1154420
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy
- (2023) Mi Ji Lee et al. CEPHALALGIA
- 059 Switching CGRP monoclonal antibodies for chronic migraine: real-world outcomes of 37 episodes
- (2022) Mark Weatherall et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
- (2022) Eleonora De Matteis et al. Therapeutics and Clinical Risk Management
- European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
- (2022) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene‐related peptide and beyond
- (2022) Michael L. Garelja et al. HEADACHE
- Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas
- (2021) P. Irimia et al. Scientific Reports
- Beyond CGRP: The calcitonin peptide family as targets for migraine and pain
- (2021) Tayla A. Rees et al. BRITISH JOURNAL OF PHARMACOLOGY
- Early Experiences in Switching between Monoclonal Antibodies in Patients with Nonresponsive Migraine in Spain: A Case Series
- (2021) Ignacio Patier Ruiz et al. EUROPEAN NEUROLOGY
- Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
- (2021) Piero Barbanti et al. HEADACHE
- Timing and durability of response to erenumab in patients with chronic migraine
- (2021) Stewart J. Tepper et al. HEADACHE
- When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?
- (2021) Claudia Altamura et al. JOURNAL OF NEUROLOGY
- Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series
- (2021) María Del Pilar Briceño-Casado et al. European Journal of Hospital Pharmacy-Science and Practice
- Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study
- (2021) Lucas Hendrik Overeem et al. CEPHALALGIA
- Timing and durability of response to erenumab in patients with episodic migraine
- (2021) Peter J. McAllister et al. HEADACHE
- In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study
- (2021) Alicia Alpuente et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – an updated systematic review and meta-analysis
- (2020) Hong Deng et al. BMC Neurology
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- The Long-Lasting Effects of “Placebo Injections” in Knee Osteoarthritis: A Meta-Analysis
- (2020) Davide Previtali et al. Cartilage
- European headache federation consensus on the definition of resistant and refractory migraine
- (2020) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
- (2020) Antonio Russo et al. JOURNAL OF HEADACHE AND PAIN
- A prospective real-world analysis of erenumab in refractory chronic migraine
- (2020) Giorgio Lambru et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study
- (2020) Piero Barbanti et al. HEADACHE
- CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
- (2019) David W Dodick CEPHALALGIA
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Monoclonal antibodies for the prevention of migraine
- (2019) Bianca Raffaelli et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Non‐Responders to Treatment With Antibodies to the CGRP‐Receptor May Profit From a Switch of Antibody Class
- (2019) Christian Ziegeler et al. HEADACHE
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapie der chronischen Migräne mit Botulinumneurotoxin A
- (2018) R. Ruscheweyh et al. NERVENARZT
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention
- (2018) Vladimir Skljarevski et al. JAMA Neurology
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
- (2013) C S Walker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
- (2008) S Silberstein et al. CEPHALALGIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now